Shigeo Nakamura - Concepedia

Author

Shigeo Nakamura

Aichi Cancer Center

Also Known As

Hiroshi Suekane, Nakamura, Shigeo, S Nakamura, SHIGEO NAKAMURA, SHIGEO Nakamura, Shigeo NAKAMURA, Shigeo Nakamura

680

Publications

32.9K

Citations

H-Index

257

Concepts

All Affiliations

Aichi Cancer Center Nagoya University Nagoya University Hospital Okayama University Dokkyo University

About

Shigeo Nakamura is an author at Aichi Cancer Center specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	168	11.9K
2	Health Sciences	15	18	2.9K
3	Engineering	8	8	383
4	Business	1	1	11
5	Natural Sciences	1	1	17

Shigeo Nakamura

351

Publications

28.4K

Citations

H-Index

Page 1

	Year	Citations
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki, Modern Rheumatology	2012	1.6K
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki, Modern Rheumatology	2012	1.5K
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee Elı́as Campo, Elaine S. Jaffe, James R. Cook, Blood ImmunologyPathologyInternational Consensus ClassificationDermatologyLymphoid Neoplasms	2022	1.4K
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Toyoaki Hida, Yasushi Yatabe, Hiroyuki Achiwa, PubMed PathologyCox-2 ExpressionCancer BiologyTumor BiologyCancer Cell Biology	1998	825
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project Wing-Yan Au, Dennis D. Weisenburger, Tanin Intragumtornchai, Blood	2008	737
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki, Modern Rheumatology General ConceptImmunodeficienciesImmunologyPathologyImmunotherapy	2012	683
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim, Journal of Clinical Oncology	2011	596
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma Javeed Iqbal, George W. Wright, Chao Wang, Blood	2014	522
Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting Maurilio Ponzoni, Andrés J.M. Ferreri, Elı́as Campo, Journal of Clinical Oncology Ivlbcl PatientsElderly PatientsImmunologyPathologyHematological Malignancy	2007	482
Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan Eiichi Ishii, Shouichi Ohga, Shinsaku Imashuku, International Journal of Hematology Lymphoid NeoplasiaHematologyHistopathologyPathologyNationwide Survey	2007	457

Page 1